General Information
Pfizer MDD DVS-3364
A Multicenter, Parallel-Group, Randomized, 10-Week, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of 50mg of Desvenlafaxine Succinate Sustained-release Formulation (DVS SR) in the Treatment of Peri-and Postmenopausal Women With Major Depressive Disorder.
| Protocol | 3151A1-3364-US |
|---|---|
| Identifier | 3151A1-3364-US |
| UID | f29e6607-5377-41dc-86a4-5761ba3f0749 |
| Status | Done - Archived |
| Phase | 4 |
| Category | Major Depressive Disorder / Adult |
| Launch Year | 2010 |
| NCT Number | - |
| Created | 2010-06-28 12:27 |
| Last Updated | 2010-06-28 12:27 |
Description
No description provided.
Comment
No comment.
Target Dates
| Name | Date | Required |
|---|---|---|
| Enrollment Closed | 2011-02-11 | No |
| Enrollment Open | 2010-08-13 | No |
| First Patient First Visit | No | |
| Site Initiation Mtg. | 2010-08-09 | No |
| PI Meeting Start | No | |
| PI Meeting End | No | |
| PI Meeting Arrival | No | |
| PI Meeting Departure | No | |
| Closeout Date | No | |
| Final PatientVisit | No | |
| PreStudy Selection Visit | No | |
| Target Date 12 | No | |
| Target Date 13 | No | |
| Target Date 14 | No |
Leadership
| Role | Staff | Login | Required |
|---|---|---|---|
| Principal | Mohaupt, Stephen | SMohaupt | No |
| Recruiter | - | No | |
| Coordinator | Calleros, Jessica | JNCalleros | No |
| Regulatory | Aguirre, Sandra | SAguirre | No |
Custom Fields
No custom fields.
Sponsor & Organization
| Sponsor | Pfizer |
|---|---|
| Division | Pfizer |
| Team | Pfizer |
| Managing Site | Catalina Research Institute, LLC |
| Organization |
Contacts
| IRB Ref | |
|---|---|
| CRO | |
| CRO Ref | |
| Correspondence | 0 |
Opportunity
| Probability | 0 |
|---|---|
| Comment | |
| Status Color | Gainsboro |
| Currency | - |
